In recent trading session, Agilon Health Inc (NYSE:AGL) saw 0.34 million shares changing hands at last check today with its beta currently measuring 0.14. Company’s recent per share price level of $2.24 trading at $0.06 or 2.75% at last check today assigns it a market valuation of $927.25M. That most recent trading price of AGL’s stock is at a discount of -245.09% from its 52-week high price of $7.73 and is indicating a premium of 33.04% from its 52-week low price of $1.50. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 3.34 million shares which gives us an average trading volume of 5.18 million if we extend that period to 3-months.
For Agilon Health Inc (AGL), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 2.80. Splitting up the data highlights that, out of 10 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 3 suggested the stock as a Hold whereas 7 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Agilon Health Inc (NYSE:AGL) trade information
Upright in the green today for gaining 2.75%, in the last five days AGL remained trading in the green while hitting it’s week-highest on Thursday, 06/26/25 when the stock touched $2.24 price level, adding 1.32% to its value on the day. Agilon Health Inc’s shares saw a change of -65.59% in year-to-date performance and have moved 2.75% in past 5-day. Agilon Health Inc (NYSE:AGL) showed a performance of 0.45% in past 30-days. Number of shares sold short was 21.23 million shares which calculate 4.81 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 4 to the stock, which implies a rise of 44.0% to its recent value today. Analysts have been projecting 2.5 as a low price target for the stock while placing it at a high target of 6.5. It follows that stock’s current price would drop -11.61% in reaching the projected high whereas dropping to the targeted low would mean a loss of -11.61% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 3.29% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 44.97% while estimates for its earnings growth in next 5 years are of 41.90%.
Agilon Health Inc (NYSE:AGL)’s Major holders
Insiders are in possession of 2.10% of company’s total shares while institution are holding 97.74 percent of that, with stock having share float percentage of 99.83%. Investors also watch the number of corporate investors in a company very closely, which is 97.74% institutions for Agilon Health Inc that are currently holding shares of the company. CLAYTON, DUBILIER & RICE, LLC is the top institutional holder at AGL for having 100.0 million shares of worth $654.0 million. And as of 2024-06-30, it was holding 24.3149 of the company’s outstanding shares.
The second largest institutional holder is FMR LLC, which was holding about 56.93 million shares on 2024-06-30. The number of shares represents firm’s hold over 13.8418 of outstanding shares, having a total worth of $372.3 million.
On the other hand, VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund and SMALLCAP WORLD FUND INC are the top two Mutual Funds which own company’s shares. As of Jan 31, 2025 , the former fund manager was holding 33.09 shares of worth $74.77 million or 7.99% of the total outstanding shares. The later fund manager was in possession of 30.86 shares on Mar 31, 2025 , making its stake of worth around $69.75 million in the company or a holder of 7.46% of company’s stock.
